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Several neuromuscular diseases involve dysfunction of neuromuscular junctions (NMJs),
yet there are no patient-specific human models for electrophysiological characterization
of NMJ. We seeded cells of neurally-induced embryoid body-like spheres derived from
induced pluripotent stem cell (iPSC) or embryonic stem cell (ESC) lines as monolayers
without basic fibroblast factor (bFGF) and observed differentiation of neuronal as well
as spontaneously contracting, multinucleated skeletal myotubes. The myotubes showed
striation, immunoreactivity for myosin heavy chain, actin bundles typical for myo-oriented
cells, and generated spontaneous and evoked action potentials (APs). The myogenic
differentiation was associated with expression of MyoD1, myogenin and type I ryanodine
receptor. Neurons formed end plate like structures with strong binding of α-bungarotoxin,
a marker of nicotinic acetylcholine receptors highly expressed in the postsynaptic
membrane of NMJs, and expressed SMI-32, a motoneuron marker, as well as SV2,
a marker for synapses. Pharmacological stimulation of cholinergic receptors resulted
in strong depolarization of myotube membrane and raised Ca2+ concentration in
sarcoplasm, while electrical stimulation evoked Ca2+ transients in myotubes. Stimulation
of motoneurons with N-Methyl-D-aspartate resulted in reproducible APs in myotubes
and end plates displayed typical mEPPs and tonic activity depolarizing myotubes of
about 10mV. We conclude that simultaneous differentiation of neurons and myotubes
from patient-specific iPSCs or ESCs results also in the development of functional
NMJs. Our human model of NMJ may serve as an important tool to investigate normal
development, mechanisms of diseases and novel drug targets involving NMJ dysfunction
and degeneration.
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INTRODUCTION
Disorders of the neuromuscular junctions (NMJs), the cholinergic synapses between lower
motoneurons and skeletal muscle fibers, include myasthenia gravis (MG) and Lambert-Eaton
myasthenic syndrome (LEMS; Liang and Han, 2013). In addition, recent studies indicate
that progressive paralyzing diseases, amyotrophic lateral sclerosis (ALS; Maselli et al., 1993;
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Frey et al., 2000; Das et al., 2010; Wu et al., 2010; Naumenko
et al., 2011; Palma et al., 2011; Thomson et al., 2012) and
spinal muscular atrophy (SMA; Russman, 2007), involve early
pathological changes at NMJ. While all these disorders belong
to the class of orphan (rare) diseases, their prevalence altogether
is 100,000—130,000 in the US, 200,000—260,000 in Europe,
and approximately 1.5–1.8 million worldwide (http://www.
rightdiagnosis.com/n/neuromuscular_conditions/prevalence.
htm). These diseases are a serious global concern as there is
no known cure for SMA (Monani and De Vivo, 2014) or ALS
(Gordon, 2013) and the currently available therapies for MG
and LEMS can cause severe adverse effects without providing
sufficient benefit for all patients.
Even though the structure and function of NMJ are
well characterized, the current understanding of the NMJ is
largely based on findings using animal models and animal
cells (reviewed in Wu et al., 2010; Thomson et al., 2012).
The lack of human models of human diseases, especially of
neurodegenerative and muscle diseases, is considered to be a
major reason for the fact that hundreds of therapies that show
excellent promise in preclinical studies do not translate to clinics
(Palma et al., 2011; Sleigh et al., 2011; Boltze et al., 2012; Thomson
et al., 2012). Therefore, there is an urgent need for development
of completely human-based NMJ models for unraveling the
molecular mechanism and therapeutic possibilities for treating
diseases involving synapse pathology, and especially the diseases
with NMJ dysfunctions. Significant progress has been made by
studies where motoneurons and muscle cells for a co-culture
were derived from human fetal spinal stem cells and adult muscle
stem cells, respectively (Guo et al., 2011). However, for modeling
diseases of genetic etiology an NMJ model where both neuron
and muscle components are derived from the same individual is
of great interest.
Availability of human pluripotent stem cells (hPSC), either of
embryonic (ESC), or induced pluripotent (iPSC) origin, hasmade
the generation of human muscle and nerve cells possible. Several
reports of hPSC differentiation into myotubes (i.e., precursors
of muscle fibers; Barberi et al., 2005, 2007; Zheng et al., 2006;
Mahmood et al., 2010; Darabi et al., 2011; Awaya et al., 2012;
Goudenege et al., 2012; Ryan et al., 2012; Abujarour et al., 2014;
Hosoyama et al., 2014) and motoneurons (Hu and Zhang, 2009;
Nizzardo et al., 2010; Hester et al., 2011; Qu et al., 2014) have
been published. Also, hPSC-derived motoneurons have been co-
cultured with rodent muscle cells or muscle cell lines but not with
muscle cells originating from cells of human embryos (ESCs)
or adult patients (iPSCs; Das et al., 2010; Guo et al., 2011).
Such an ESC or iPSC-derived model of NMJ would be useful,
allowing the neuronal and muscle components of the NMJ to be
derived from the same individual (reviewed in Thomson et al.,
2012). Moreover, especially human iPSC-derived NMJ models
would provide new insights into the mechanisms of genetic
diseases involving NMJ dysfunction, help patient stratification,
and further enable the design of personalized therapy.
Production of highly pure population of the final cell types,
e.g., specific types of neurons or myofibers, has been one of the
major obstacles in the differentiation processes of hPSCs (Chiu
and Rao, 2011; Salani et al., 2012). While high purity of the final
cell type is indeed desired for many experimental set-ups, such as
cell-specific expression analyses of genes or proteins, most of the
cellular functions and disease pathologies depend on several cell
types and their interaction. This view is valid also for the diseases
involving NMJ dysfunction, such as ALS, SMA, MG, and LEMS
(Palma et al., 2011; Thomson et al., 2012; Liang and Han, 2013).
Therefore, the cell culture models of NMJ in which neurons
and muscle cells develop in interaction with each other might
be the most relevant ones. Although hiPSC-derived cell models
are not likely to reach fully mature phenotype in culture in vitro
(Yoshida et al., 2015), the models with functional NMJs would be
valuable in studying development of pathology associated with
genetic disorders and developmental assembly of human NMJs
in general.
We have earlier reported that the human ESCs differentiated
into neural progenitors (NPCs) in a suspension produce small
spindle-shaped cells that further differentiate into neural cells,
and large flat cells that are negative for a variety of neuronal
and glial markers (Puttonen et al., 2013). Here we report
that a portion of the non-neural flat cells differentiate into
myogenic cells and form multinucleated skeletal myotubes in
the environment designed for neural induction, proliferation
and maturation. Importantly, the presence of progenitors for
both neurons and skeletal muscle cells allow co-maturation of
these two cell types, resulting in formation of functional NMJs.
Therefore, by taking advantage of the apparent developmental
interdependency of skeletal muscle cells and motoneurons, and
their parallel derivation from hPSCs of the very same individual,
our novel model may serve as an important tool to investigate
normal development and mechanisms of diseases involving NMJ
dysfunction and degeneration.
MATERIALS AND METHODS
Maintenance of Human PSC Cultures
Human ESCs (line HS306, originally derived at Karolinska
Institutet, Stockholm, Sweden) and hiPSCs (lines UEFhfiPS1.4
and UEFhAD2fiPS1.2) reprogrammed and characterized in our
laboratory (Qu et al., 2013, unpublished data) were cultured
as previously described (Puttonen et al., 2013). Ethics approval
(No: 42/2010) was obtained by Pohjois-Savon Sairaanhoitopiirin
kuntayhtymä, Tutkimuseettinen toimikunta, and individuals
donating skin samples gave informed consent before taking part
in the study.
Differentiation of Embryoid Body-like
Spheres and Induction of Maturation
Neural differentiation of HS306, UEFhfiPS1.4 and
UEFhAD2fiPS1.2 lines was performed as previously described
(Puttonen et al., 2013) except that at the end of the differentiation
period (>6 weeks after induction of differentiation) and prior
to plating down the individual cells, the spheres were not
selected for the experiments but all types and sized spheres
were collected. Thus, we ensured that not only neurospheres
and neural progenitors but also heterogeneous embryoid body
(EB) –like large spheres containing non-neuronal cells were
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included (Puttonen et al., 2013). Terminal maturation of the
cells was performed as described (Puttonen et al., 2013). Briefly,
dissociated progenitor cells (1 × 105 cells/cm2) were seeded
on polyornithine and laminin-coated wells in the medium
containing 1:1 mix of DMEM/F12 and Neurobasal media,
1x retinoic acid free B27, 1x N2, 2mM Glutamax, 50 IU/ml
Penicillin and 50µg/ml Streptomycin (all from Invitrogen,
Carlsbad, CA), and maintained at 37◦C and 5% CO2 for 5–7
days until performing analyses. Medium was changed every
second day. For some batches the terminal maturation phase
was recorded by a continuous live cell imaging system, Cell-IQ
v.2, equipped with a phase-contrast microscope and a 10X
objective (Chip-Man Technologies, Tampere, Finland). The
plates of monolayered cells were covered with a Cell-Secure lid
(Chip-Man Technologies) containing ventilation filters. The
incubation conditions were maintained at 37◦C, 5% CO2, 19%
O2, and 76% N2. The medium was changed every other day. The
culture was time-lapse imaged every 30min for 6 days with an
Imagen™ Mode. Image selection and video reconstruction was
made by an Analysis™Mode.
Labeling of Cells for Fluorescence
Microscopy
Immunocytochemical labeling was performed as described
(Puttonen et al., 2013) for all cell lines/differentiation batches.
Primary antibodies were anti-doublecortin (DCX; 1:400; 4604,
Cell Signaling Technology, Danvers, MA) and anti-βIII-tubulin
(Tuj1; 1:1000; MMS-435P; Covance, San Diego, CA) for
neurons, Neurofilament H Non-Phosphorylated (SMI 32)
Monoclonal Antibody (1:1000; SMI-32P; Covance, Princetown,
NJ) for motoneurons [36], anti-synaptic vesicles (SV2; 1:100;
Developmental Studies Hybridoma Bank, Iowa, IA) and anti-
Synaptophysin (anti-Synaptophysin; 1:100; Abcam, 14692,
Cambridge, UK) for synapses, and anti-Myosin heavy chain
(MHC clone A4.1025; 1:400; 05-716; Millipore, Billerica, MA)
for myotubes. Alexa Fluor R© goat anti-mouse and anti-rabbit
488 and 568 (1:300; Molecular Probes R©, Invitrogen) were
used as the secondary antibodies. Acetylcholine receptors of
NMJs were visualized by staining with 0.25–1µM Alexa Fluor
488 or 594 α-bungarotoxin (B13422 and B13423, Molecular
Probes R©, Invitrogen). Alexa Fluor 488 Phalloidin (25 nM;
Molecular Probes R©, Invitrogen) was used for labeling F-actin in
microfilaments to visualize the finest cytoskeletal organization of
the myogenic cells. Fluorescently labeled cultures were imaged
and analyzed with an Olympus DP70 digital camera attached
to an Olympus IX71 inverted epifluorescence microscope
(Hamburg, Germany) or with a FluoView 1000 (Olympus,
Japan) confocal microscope.
Quantitative RT-PCR (qRT-PCR)
The extraction of total RNA, reverse transcription, and qRT-PCR
analyses were performed as described earlier (Puttonen
et al., 2013). TaqMan gene expression assays (Applied
Biosystems) containing FAM dye were used to measure the
RNA expression of microtubule-associated protein (MAP2,
Hs00258900_m1), paired box protein (PAX6, Hs00242217_m1),
myogenic differentiation 1 (MyoD1, Hs02330075_g1), myogenin
(MYOG, Hs01072232_m1) and ryanodine receptor 1 (RYR1,
Hs00166991_m1) genes. For each sample the expression of
endogenous β–actin ACTB gene containing VIC-dye (Applied
Biosystems) was determined and used for normalization.
Ca2+ Imaging and Patch-Clamp
Recordings
For Ca2+ imaging the attached cells were loaded with 5µMFluo-
4-acetoxymethyl (AM)-ester (Invitrogen) at 37◦C for 30min, and
then placed in the recording chamber continuously perfused with
preheated (37◦C) Dulbecco’s modified Eagle medium containing
glutamax I (DMEM; Invitrogen) and bubbled with 95% O2 and
5% CO2. To excite the cells, a stimulator (Grass, USA) and
platinum wires were used. In some experiments acetylcholine
(100µM, Sigma) was added in bath solution to activate nicotinic
receptors. Ca2+ imaging was performed with a confocal inverted
microscope (FluoView 1000, Olympus). The cells were excited
at 488 nm and the emitted light band was set at 500–600 nm.
The fluorescence intensity is expressed as an F/F0 -ratio, where
F is the background subtracted fluorescence intensity and F0
is the background subtracted minimum fluorescence value
measured from each cell at rest. The electrical activity and
action potentials (APs) were measured in the same chamber
by conventional whole-cell patch recording in a current clamp
mode (Axopatch 200B, Digidata 1440A, Molecular Devices Inc.,
USA). Patch electrodes (3–4 M) made of borosilicate glass
(HarvardApparatus, UK)were filled with (mM): 120 K-aspartate,
25 KCl, 1 MgCl2, 2 Na2-phosphocreatine, 4 Na2-ATP, 2 NaGTP,
10 EGTA, and 5HEPES, pH 7.2 with KOH [36]. Evoked APs were
elicited by a 1ms current injection. For chemical stimulation
carbacholine (100µM, Sigma) or NMDA (500µM, Sigma) were
applied directly to the studied area with local perfusion manifold
(Cell MicroControls, USA).
Statistics
The statistical significance of the data was analyzed with paired
T-test using GraphPad Prism version 5 (GraphPad Software,
Inc., San Diego, CA). P < 0.05 were considered statistically
significant.
RESULTS
Differentiation of Myotubes in Neural Cell
Co-cultures
To investigate the differentiation fate of the non-neural cells, we
seeded cells from all sphere types derived from iPSC or ESC
lines onto polyornithine-laminin coated wells as monolayers,
and withdrew basic fibroblast factor (bFGF) from the growth
medium. As expected, 7 days later cells with a typical NPC
morphology were seen (Figure 1A, white arrows). However,
we also observed a large number of spontaneously contracting
(Video S1), multinucleated cells (Figures 1A,B). Some of these
cells exhibited striation characteristics for skeletal muscle
cells (Figure 1B). During the terminal differentiation phase,
continuous live cell imaging revealed spontaneous fusion of
muscle precursors and subsequent formation of myotubes
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FIGURE 1 | Cells from non-selected spheres mature into neurons and
myotubes derived from ESCs (HS306). Cell populations contain neural
progenitors and mature neurons with neurites (A, white arrows), and
non-striated (A, black arrows) and striated (B) multinucleated myotubes. In
these cultures, myotubes are spontaneously contracting (A, Video S1).
Eventually, the contraction and movement may lead to the detachment and
further degeneration of the myotube (A, black arrowhead). Time-lapse imaging
of the same view reveals that myoprecursors and myotubes are highly mobile,
and the fusion of precursor cells into myotubes is a dynamic process (C,D,
Video S2). Scale bars: (A) 100µm; (B) 50µm; (C,D) 100µm.
(Figures 1C,D;Video S2). Notably, the mature myotubes tended
to detach from the culturing plate due to their twitching.
Immunofluorescence labeling with anti-neuron specific class
III β-tubulin (Tuj1) and anti-MHC, a marker of muscle cells,
confirmed that purely neurally oriented cultures seeded from
selected spheres lacked myogenic, MHC-immunoreactive
cells (Figures 2A,B). Instead, in cultures derived from
all types of spheres maturation of both neuronal (Tuj1-
immunoreactive) and myogenic (MHC-immunoreactive)
markers was seen (Figures 2C,D). In addition, Phalloidin
488 staining of the myotube-like cells revealed actin bundles
typical for myo-oriented cells (Figure 2E) and in some
MHC-immunostained myotubes the striation was visible
(Figure 2F). Finally, quantitative RT-PCR demonstrated that the
expression of neuroectodermal (Pax-6) and neuronal (Map-2)
genes was several fold lower in myotube-containing cultures
compared to cells of neuron-enriched batches (Figures 3A,B).
Correspondingly, the expression of MyoD1, a master gene of
myogenic process, and the two genes describing the terminal
maturation of myotubes, Myogenin and type I Ryanodine
FIGURE 2 | Immunostaining confirms that the cells from non-selected
spheres mature into neurons and myotubes. Neurosphere-derived cells
mature predominantly (>90%) into neuron specific, class III β-tubulin (Tuj1)
positive neurons with small nuclei and long projections (A, white arrows).
These cells do not express a skeletal muscle marker myosin heavy chain
(MHC) (B). Non-selected (mixed) spheres produce both neurons (C) and thick
MHC positive (D) myotubes (D, white arrows) that are also positive to
phalloidin (E), labeling the actin filaments of myo-oriented cells. In some MHC
positive myotubes, the striation is visible (F, white arrows). In (A–F) the nuclei
were stained with Hoechst 333042 (blue). Scale bars: (A–D) (iPSC-derived),
100µm; (E) (ESC-derived), 50µm; (F) (iPSC-derived), 30µm.
receptor (Goudenege et al., 2012; Tran et al., 2013) were
significantly, more than 160-fold, higher in cultures containing
myotubes compared to the differentiation batches that were
purely neural (Figures 3C–E).
Cytochemical Identification of NMJ
Having shown the co-maturation of neurons and myotubes in
our cell culture model of hPSC-derived cells, we next investigated
whether the two cell types are synaptically connected to each
other. NMJ is a special type of synapse in which the AP of
a motoneuron leads to activation (contraction) of innervated
muscle fibers (Das et al., 2010; Wu et al., 2010).
Phase-contrast microscopy and immunocytochemical
analyses showed intimate connections between neuronal
processes and myotubes derived from iPSC and ESC lines
(Figure 4A). Neuronal processes immunoreactive for neuron-
specific type III β-tubulin (Tuj1) were observed to surround
phalloidin positive myotubes derived from either iPSC or ESC
lines (Figure 4B). Varicose doublecortin immunoreactive nerve
fibers on myotubes expressed also synaptic vesicle protein 2
(SV2), a membrane glycoprotein found in the secretory vesicles
of neural cells (Custer et al., 2006; Figure 4C). Moreover,
in line with the idea of NMJ formation in these cultures,
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FIGURE 3 | Neural genes (A,B) are strongly down-regulated and myogenic markers (C–E) up-regulated in the non-selected (mixed) sphere-derived cell
populations when compared to neurospheres. Results are shown as the normalized expression of the target genes against the expression of the endogenous
β-actin gene. Results are expressed as mean ± SD, n = 4, and analyzed with paired T-test, ** <0.005, *** <0.001. Map-2, microtubule- associated protein; MyoD1,
myogenic differentiation 1; Myog, myogenin; Pax-6, paired box protein; RYR1, ryanodine receptor 1. All cells were derived from iPSCs.
a portion of the neurons expressed a non-phosphorylated
epitope in neurofilament H (SMI-32), a motoneuron marker
(Figure 4D). Finally, when NMJs were labeled with fluorogenic
α-bungarotoxin, a specific marker of nicotinic acetylcholine
receptors (nAChR) known to be densely expressed in the
NMJ postsynaptic membrane (Bruneau et al., 2005), bright
fluorescence was observed at end plates (Figure 4E) and
colocalized with synaptophysin immunoreactivity (Figure 4F).
These results led us to hypothesize that both the neuronal cells
and the postsynaptic membranes present in myotubes of our
human co-culture model are mature enough to form functional
NMJs.
Functional Properties of Myotubes and
NMJs
To confirm that the myotubes and NMJs identified in our co-
culture model are functional, we applied electrophysiology and
live cell Ca2+ imaging to characterize the spontaneous and
induced myotube responses. As expected, myotubes had an
ability to generate spontaneous and evoked APs (Figures 5A,B).
Myotubes had relatively low resting membrane potential (65–
80mV) and the AP waveform was variable, especially the AP
duration showed large variability ranging from relatively narrow
spike-like AP to ones that lasted up to 200ms. The finding
indicates that among cells showing myotube morphology the
degree of maturation differed from cell to cell.
To examine functionality of our NMJ model, we first
stimulated the cultures with carbacholine, a cholinomimetic
that binds and activates nAChRs in the NMJ postsynaptic
membrane (Nachev et al., 2008). At 100µM concentration,
carbacholine produced fast and strong depolarization of the
myotube membrane (Figure 5C), in line with the localization
of dense α-bungarotoxin binding observed in end plate-like
structures. To see if membrane depolarizations trigger muscle-
type cytosolic calcium signals (Hernández-Ochoa and Schneider,
2012), we measured intracellular Ca2+ signals in fluo-4 loaded
cells after electrical field stimulation of myotubes. As seen in
Figure 5E, 0.5Hz electrical stimulation of myotubes evoked
strong Ca2+ transients in myotubes. Moreover, application
of 100µM acetylcholine induced robust calcium elevation in
sarcoplasm (Figure 5D).
Next, we analyzed whether excitation of motoneurons
results also in activation of myotubes, thereby indicating
functionality of the NMJs. The most well-known excitatory
receptors expressed by motoneurons but not by myotubes
are glutamatergic receptors, especially N-Methyl-D-aspartate
(NMDA) receptors (Vartiainen et al., 1999). Thus, we applied
micromolar concentrations of NMDA to our co-culture model
and observed reproducible APs in myotubes, confirming that
neurons contacting myotubes are both presynaptically and
postsynaptically mature and that NMJs between NMDA-
activated neurons andmyotubes are truly functional (Figure 6A).
Spontaneous ACh release into synaptic cleft accomplished
by both quantal and non-quantal manner (Katz and Miledi,
1977) is an essential feature of NMJs. A single quantum of
ACh brings about the appearance of one miniature end-plate
potential (mEPPs), whereas non-quantal secretion of ACh results
in a tonic effect on postsynaptic resting membrane potential
(Stanley and Drachman, 1979; Urazaev et al., 2000). As seen in
Figure 6B, the human myotubes in our culture model generated
mEPPs with characteristics completely matching to those of
the mEPPs previously reported for primary skeletal muscle
cells (Santafé et al., 2003). When analyzing 330 myotubes
from 30 different culture wells, 34 functional NMJs with
detectable and reliable mEPP were identified. Considering that
mEPPs cannot be expressed without functional presynaptic and
postsynaptic counterparts of NMJs, our data indicate that at least
300 functional NMJs per 300 000 cells in each culture wells
were present. Moreover, typical to innervated muscle cells, the
myotubes in our cell culture model demonstrated fast and strong
hyperpolarization (9.6± 1.3mV, n = 8) upon a local application
of nicotinic receptor blocker (Figure 6C), a phenomenon known
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FIGURE 4 | Neurons and myotubes that are in close proximity seem to
connect with each other potentially via neuromuscular junction (NMJ).
A representative phase contrast image (A; ESC-derived) shows an elongated
muscle cell contacting with two neuronal cells (arrows). Immunocytochemistry
shows that neuron specific III β-tubulin (Tuj1) positive neuronal cells (B;
iPSC-derived, in red) grow along and surround the phalloidin positive
myotubes (in green). A proportion of doublecortin (DCX) positive neurons (C;
iPSC-derived, in red; also myotubes express DCX) express a synaptic protein,
synaptic vesicles (SV2; C in green). In (D) (iPSC-derived), DCX positive
neurons (in red) contacting with multinucleated myotubes co-express (in
yellow) neurofilament H (SMI-32; in green), a motoneuronal protein. In (E)
(ESC-derived), α-bungarotoxin (in green) specifically binding to the nicotinic
acetylcholine receptors densely expressed at the postsynaptic site of NMJ is
detected on the surface of myotubes (the phase contrast insert shows
presumably a neuron contacting the myotube). In (F) (confocal image,
iPSC-derived), a thick myotube (big white arrow) expressing post-synaptic
membranes, visualized with red-labeled α-bungarotoxin, is contacting with a
synaptophysin positive nerve ending (green; small white arrow). At the site of
NMJ the colocalization is seen (in yellow color; yellow big arrow). In (B–D) the
nuclei were stained with Hoechst 33042 (blue). Scale bars: (A–D), 50µm;
(E,F), 10µm.
to occur in innervated but not in non-innervated muscle
cells (Sun and Poo, 1985). Altogether, our electrophysiological
results indicate that ACh is spontaneously released into
NMJs by both quantal and non-quantal manner in our cell
culture model.
DISCUSSION
We have reported earlier that a large amount of NPCs can be
produced from hPSCs by growing cells in spheres in the neural
induction and proliferation medium (Puttonen et al., 2013).
Yet, when no pre-selection methods are applied, the cultures
produce not only neurospheres but also EB-like spheres that
contain predominantly non-neural cells (Puttonen et al., 2013).
Here we show that the EB-like spheres that are produced in
addition to neurospheres from hESCs or hiPSCs (in floating
aggregates) in neural proliferation medium give rise to myotubes
and neurons, when the spheres are dissociated and maintained
as adherent cultures after withdrawal of FGF. The data indicates
FIGURE 5 | Functional characterization of iPSC-derived myotubes. (A)
Membrane potential (Vm) recording of spontaneously active myotube showing
repetitive firing and narrow spike-like APs. (B) In part of the myotubes current
injection evokes a single relatively long AP. (C) Carbacholine application (red
arrow) causes strong depolarization of the myotube membrane. Note the fast
phase (inset) most likely induced by the current through nAChR. (D)
Acetylcholine (100µM) application (red arrow) induces a robust increase in
cytosolic [Ca2+] of the myotubes, whereas (E) 0.5Hz electrical stimulation (red
arrows) evokes repetitive calcium transients in myotubes. All traces are
representative examples out from at least 15 recordings.
that cells originating from a single individual can be differentiated
into both neurons and myotubes in the same cultures when
cells from all sized and heterogenous spheres are included
in the terminal differentiation phase. This is in line with the
previous reports demonstrating that the medium optimized for
neural differentiation does not prevent the random formation
of various types of spheres containing numbers of non-neural
cells (Nat et al., 2007; Puttonen et al., 2013; Hosoyama et al.,
2014). More importantly, our data shows that the culture
medium containing FGF during the 6-week neural proliferation
phase followed by brief neural differentiation phase as adherent
cultures without FGF favors differentiation of both neurons and
myotubes. While Hosoyama et al. (2014) reported that hPSC
sphere cultures give rise to myogenic progenitor cells when
hPSC colonies were expanded in the medium containing high,
100 ng/ml concentrations of FGF and EGF, our results show that
the neural proliferation medium containing low concentration
(25 ng/ml) of FGF is sufficient for myogenic differentiation
without compromising the proliferation and differentiation of
neuronal cells.
The molecular machinery required for synaptic transmission
was present in post-synaptic membranes of myotubes developed
in our co-culture system, as evidenced by the dense α-
bungarotoxin binding at end plate-like structures, the fast and
strong depolarization of myotubes induced by carbacholine, and
transient Ca2+ signals induced by acetylcholine or in response to
electrical stimulation. Even though the properties of the resting
and action potential indicated that maturation phase of the
myotubes varied from cell to cell, the postsynaptic membranes
present in myotubes of our human co-culture model were
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FIGURE 6 | Functional characterization of NMJs in iPSC-derived cells. (A) Activation of NMDARs in neurons by application of NMDA (500µM, red arrow)
induces AP firing of adjacent myotubes. (B) Membrane potential recording of miniature end-plate potentials (mEPPs) of myotubes (upper line), example of expanded
mEPP trace (lower line, right part) and main characteristics of mEPP (lower line, left part, mEPP: amplitude, rise time (RT) and decay of mEPP). (C) Hyperpolarizing
effect (H-effect) of nimbex (2µM) a nicotinic receptor blocker on resting membrane potential (application—the first red arrow, wash—the second red arrow). All traces
are representative examples out from at least 8 recordings.
mature enough to form functional NMJs. While there are no
previous reports on electrophysiological properties of hPSC-
derived myotubes available, our findings are in line with results
obtained from cultured myotubes derived from human and
mouse satellite cells (Das et al., 2010; Guo et al., 2011; Yoshida
et al., 2015) and confirm that our hPSC-derived myotubes
closely resemble myotubes that are obtained without genetic
reprogramming and differentiated in co-culture with neurally
oriented cells.
The finding of the non-quantal release of ACh into the
NMJ clefts of our co-culture system can be considered to
indicate active NMJ formation and maintenance (Fu et al.,
1998). This notion is supported by the previous studies reporting
that spontaneous ACh release appears at embryonic nerve
cones prior to synapse formation (Young and Poo, 1983) and
during the development of embryonic myotubes before they
become innervated (Fu et al., 1998). Importantly, presynaptic
nicotinic receptors and muscarinic receptors at nerve ending
of developing motoneurons, which were identified also in our
NMJ model, modulate the spontaneous release of ACh (Santafé
et al., 2003). The mechanisms of how non-quantally released
ACh may promote NMJ maturation and maintenance include its
function as a specific chemoattractant for growth cone guidance
(Zheng et al., 1994) and its contribution to the anterograde
and retrograde signaling between presynaptic and postsynapic
membranes (Dan and Poo, 1994; Urazaev et al., 2000), the
latter being considered to be an interaction mandatory for the
successful development and function of synapses (Katz and
Miledi, 1977; Mathers and Thesleff, 1978; Bray et al., 1982; Young
and Poo, 1983; Vyskocil and Vrbová, 1993; Dan and Poo, 1994;
Fu et al., 1998; Urazaev et al., 2000). Because, non-quantal release
is more pronounced in developing endplates than in fully mature
end plates (Vyskocil and Vrbová, 1993), reflecting its important
role in NMJ development overall, our cell culture system may
well serve to model the development of human NMJ.
To our knowledge, this is the first report on simultaneous
differentiation of functionally mature neurons and myotubes,
and more importantly, formation of functional neuromuscular
units, in cultures consisting of cells that are derived from single
hPSC lines (iPSCs and ESCs). Our results are supported by
a recent study showing differentiation of myotubes in parallel
with neural cells from hPSCs when evaluated by using histology
and gene expression analysis (Hosoyama et al., 2014). The
most significant novelty of our study is the demonstration of
functional NMJs derived from human iPSC and ESC lines,
allowing modeling of the NMJ derived from single individuals.
Previous studies have shown quite comparable results when
taking advantage of human fetal spinal cord stem cells and
human muscle progenitor cells derived from satellite cells
(Guo et al., 2011). In our co-culture system neural precursor
cells/neurons and myogenic precursors/myotubes grow in
intimate interaction with each other during the whole period
of development, from the pluripotent stem cell phase until
maturation of the NMJ that can be stimulated by current
induction and pharmacologically. It is evident that such a long-
term co-development of cells representing both presynaptic and
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postsynaptic cells of NMJ is needed for full maturation of NMJs.
Although our co-culture model is still lacking the presence of
two other components of the NMJ, Schwann cells and kranocytes
(Thomson et al., 2012) the model may be useful for revealing
developmental mechanisms of human NMJ as well as studying
NMJ diseases.
Collectively, we demonstrate that myotubes derived from
human PSC lines have excitable membrane with variety of
ion conductances, mechanisms for generating muscle-cell type
of calcium signals, and form functional end plates with co-
differentiating neurons which are sufficient to activate myotube
contraction. In a wider context, our results demonstrate for the
first time that it is possible to generate two different types of
cells from the same origin, which eventually form a functional
connection with each other. This discovery opens up new
avenues not only for cell therapy but also for tissue engineering
and research of human diseases.
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